The Current Ratio as of September 2024 (TTM) for Cingulate Inc. (CING) is 1.20

According to Cingulate Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.20. This represents a change of 61.96% compared to the average of 0.74 of the last 4 quarters.

Cingulate Inc. (CING) Historical Current Ratio (quarterly & annually)

How has CING Current Ratio performed in the past?

The mean historical Current Ratio of Cingulate Inc. over the last ten years is 3.61. The current 1.20 Current Ratio has changed 3.21% with respect to the historical average. Over the past ten years (40 quarters), CING's Current Ratio was at its highest in in the December 2021 quarter at 16.05. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Cingulate Inc. (CING) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cingulate Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cingulate Inc. (CING) Average Current Ratio

How has CING Current Ratio performed in the past?

The current Current Ratio of Cingulate Inc. (CING) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cingulate Inc. (CING) Current Ratio vs. Peers

How is CING’s Current Ratio compared to its peers?

Cingulate Inc.’s Current Ratio is less than SAB Biotherapeutics, Inc. (0), less than Senti Biosciences, Inc. (5.24), less than Bellicum Pharmaceuticals, Inc. (4.89), less than Hillstream BioPharma, Inc. (3.04), less than Aerovate Therapeutics, Inc. (2.25), less than Adagene Inc. (6.51), less than Acrivon Therapeutics, Inc. Common Stock (2.50), less than Rezolute, Inc. (16.16), less than AN2 Therapeutics, Inc. (11.82), less than Genelux Corporation (10.61), less than Comera Life Sciences Holdings, Inc. (6.01), greater than Dyadic International, Inc. (0.90), less than Monopar Therapeutics Inc. (5.39), less than Miromatrix Medical Inc. (6.59), less than Inhibikase Therapeutics, Inc. (3.46), less than PMV Pharmaceuticals, Inc. (2.32), less than Anebulo Pharmaceuticals, Inc. (19.22), less than null (5.32),

Build a custom stock screener for Cingulate Inc. (CING) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cingulate Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cingulate Inc. (CING) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cingulate Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.